Ecolab Inc. reported third quarter 2025 sales growth of 4%, with organic sales up 3%. The increase was driven by value price acceleration to 3% from 2% and 1% volume growth. The Institutional & Specialty segment saw sales increase by 3%, with growth in sales to hospitality customers and lower sales to hospitals. The Food & Beverage segment recorded accelerating growth, while Life Sciences reported a 6% sales increase, led by double-digit growth in bioprocessing and pharmaceutical sales. The company recorded reported diluted EPS of $2.05 and adjusted diluted EPS of $2.07, representing a 13% increase.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ecolab Inc. published the original content used to generate this news brief on October 28, 2025, and is solely responsible for the information contained therein.